{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:24:12Z","timestamp":1794551052506,"version":"4.9.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013510","name":"Eye and Tissue Bank Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005878","name":"Research Council for Health","doi-asserted-by":"publisher","award":["344718"],"award-info":[{"award-number":["344718"]}],"id":[{"id":"10.13039\/501100005878","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.biopha.2026.119387","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:43:18Z","timestamp":1776915798000},"page":"119387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Sustained intravitreal dissolution and kinase inhibition by an inhibitory cGMP analogue after its injection as a suspension of a poorly soluble salt"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8713-8981","authenticated-orcid":false,"given":"Eetu","family":"Valkama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Toropainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2902-5899","authenticated-orcid":false,"given":"Simar Pal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Valtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Koskela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3917-3107","authenticated-orcid":false,"given":"Arto","family":"Merivaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4941-5915","authenticated-orcid":false,"given":"Oswaldo","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Ruponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Groten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3401-0728","authenticated-orcid":false,"given":"Nicolaas","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arto","family":"Urtti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3225-9186","authenticated-orcid":false,"given":"Kati-Sisko","family":"Vellonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6234-9193","authenticated-orcid":false,"given":"Tatu","family":"Lajunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooseppi","family":"Puranen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119387_bib1","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","article-title":"Retinitis pigmentosa","volume":"368","author":"Hartong","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119387_bib2","unstructured":"RetNet - Retinal Information Network, (n.d.). \u3008https:\/\/retnet.org\/\u3009 (accessed January 10, 2025)."},{"key":"10.1016\/j.biopha.2026.119387_bib3","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1471-4159.2008.05822.x","article-title":"PKG activity causes photoreceptor cell death in two retinitis pigmentosa models","volume":"108","author":"Paquet-Durand","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2026.119387_bib4","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/hmg\/ddq539","article-title":"A key role for cyclic nucleotide gated (CNG) channels in cGMP-related retinitis pigmentosa","volume":"20","author":"Paquet-Durand","year":"2011","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2026.119387_bib5","doi-asserted-by":"crossref","first-page":"E2997","DOI":"10.1073\/pnas.1718792115","article-title":"Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration","volume":"115","author":"Vighi","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2026.119387_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/iovs.65.12.14","article-title":"Comprehensive pharmacokinetic evaluation of high melanin binder levofloxacin in rabbits shows potential of topical eye drops for posterior segment treatment","volume":"65","author":"Bahrpeyma","year":"2024","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2026.119387_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drudis.2007.11.002","article-title":"Current and future ophthalmic drug delivery systems: a shift to the posterior segment","volume":"13","author":"del Amo","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2026.119387_bib8","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2026.119387_bib9","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.2147\/OPTH.S558098","article-title":"Qualitative factors impacting patients and clinicians regarding intravitreal injections for retinal disorders: a scoping review","volume":"19","author":"Ly","year":"2025","journal-title":"Clin. Ophthalmol. Auckl. NZ"},{"key":"10.1016\/j.biopha.2026.119387_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.exer.2015.05.003","article-title":"Rabbit as an animal model for intravitreal pharmacokinetics: Clinical predictability and quality of the published data","volume":"137","author":"del Amo","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2026.119387_bib11","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.drudis.2019.02.001","article-title":"Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties","volume":"24","author":"Subrizi","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2026.119387_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107291","article-title":"Drug release and pharmacokinetics of intravitreal liposomal injections: a case study with cyclic guanosine monophosphate derivative","volume":"214","author":"Valkama","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2026.119387_bib13","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1039\/D5BM00453E","article-title":"Recent advances and future perspectives of long-acting ophthalmic preparations (LAOPs) in clinical applications","volume":"13","author":"Wang","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biopha.2026.119387_bib14","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1167\/iovs.12-11460","article-title":"Different intravitreal properties of three triamcinolone formulations and their possible impact on retina practice","volume":"54","author":"Chen","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2026.119387_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/jop.2019.0072","article-title":"Dexamethasone intraocular suspension: a long-acting therapeutic for treating inflammation associated with cataract surgery","volume":"35","author":"Grzybowski","year":"2019","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2026.119387_bib16","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/00006982-200412000-00009","article-title":"Intravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyes","volume":"24","author":"Mason","year":"2004","journal-title":"RETINA"},{"key":"10.1016\/j.biopha.2026.119387_bib17","doi-asserted-by":"crossref","unstructured":"Solubility and Dissolution of Triamcinolone Acetonide, J. Pharm. Sci. 62 (1973) 617\u2013621. \u3008https:\/\/doi.org\/10.1002\/jps.2600620416\u3009.","DOI":"10.1002\/jps.2600620416"},{"key":"10.1016\/j.biopha.2026.119387_bib18","series-title":"StatPearls","article-title":"Benzathine Penicillin","author":"Gartlan","year":"2025"},{"key":"10.1016\/j.biopha.2026.119387_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/open.202300141","article-title":"Crystal modifications of a cyclic guanosine phosphorothioate analogue, a drug candidate for retinal neurodegenerations","volume":"12","author":"P\u00e9rez","year":"2023","journal-title":"ChemistryOpen"},{"key":"10.1016\/j.biopha.2026.119387_bib20","unstructured":"PubChem, 3-[(4aR,6 R,7 R,7aS)-2,7-dihydroxy-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-2-bromo-6-phenyl-5H-imidazo[1,2-a]purin-9-one, (n.d.). \u3008https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/6913617\u3009 (accessed March 9, 2026)."},{"key":"10.1016\/j.biopha.2026.119387_bib21","unstructured":"PubChem, N-Benzylphenethylamine, (n.d.). \u3008https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/65055\u3009 (accessed March 9, 2026)."},{"key":"10.1016\/j.biopha.2026.119387_bib22","unstructured":"PubChem, Benzathine, (n.d.). \u3008https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/8793\u3009 (accessed March 9, 2026)."},{"key":"10.1016\/j.biopha.2026.119387_bib23","unstructured":"Rowan | ML-Powered Molecular Design and Simulation, Rowan Doc. (n.d.). \u3008https:\/\/www.rowansci.com\u3009 (accessed March 9, 2026)."},{"key":"10.1016\/j.biopha.2026.119387_bib24","doi-asserted-by":"crossref","first-page":"30626","DOI":"10.1021\/jacs.5c02578","article-title":"Solvation free energies of anions: from curated reference data to predictive models","volume":"147","author":"Nevolianis","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2026.119387_bib25","article-title":"Efficient and accurate pka prediction enabled by pre-trained machine-learned interatomic potentials","author":"Wagen","year":"2024","journal-title":"ChemRxiv"},{"key":"10.1016\/j.biopha.2026.119387_bib26","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11095-009-0021-1","article-title":"Understanding the behavior of amorphous pharmaceutical systems during dissolution","volume":"27","author":"Alonzo","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2026.119387_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113823","article-title":"Novel in vitro model for intravitreal drug dissolution and release studies of small molecules and their long-acting formulations","volume":"383","author":"Sorsa","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119387_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121800","article-title":"Imaging, quantitation and kinetic modelling of intravitreal nanomaterials","volume":"621","author":"Sadeghi","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2026.119387_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114260","article-title":"Comprehensive ocular and systemic pharmacokinetics of dexamethasone after subconjunctival and intravenous injections in rabbits","volume":"198","author":"Valtari","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2026.119387_bib30","series-title":"T-Cell Motil. Methods Protoc","first-page":"99","article-title":"Profiling activity of cellular kinases in migrating T-Cells","author":"Chirumamilla","year":"2019"},{"key":"10.1016\/j.biopha.2026.119387_bib31","series-title":"Ggplot2 Elegant Graph. Data Anal","first-page":"189","article-title":"Data analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.biopha.2026.119387_bib32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1039\/C5MB00663E","article-title":"ReactomePA: an R\/Bioconductor package for reactome pathway analysis and visualization","volume":"12","author":"Yu","year":"2016","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.biopha.2026.119387_bib33","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.3390\/ijms25063446","article-title":"Integrative kinase activity profiling and phosphoproteomics of rd10 mouse retina during cGMP-dependent retinal degeneration","volume":"25","author":"Roy","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119387_bib34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10719-017-9808-1","article-title":"Glycosaminoglycans from bovine eye vitreous humour and interaction with collagen type II","volume":"35","author":"Peng","year":"2018","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.biopha.2026.119387_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejpb.2015.01.003","article-title":"Intravitreal clearance and volume of distribution of compounds in rabbits: In silico prediction and pharmacokinetic simulations for drug development","volume":"95","author":"del Amo","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2026.119387_bib36","doi-asserted-by":"crossref","unstructured":"Ocular metabolism and distribution of drugs in the rabbit eye: Quantitative assessment after intracameral and intravitreal administrations, Int. J. Pharm. 613 (2022) 121361. \u3008https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121361\u3009.","DOI":"10.1016\/j.ijpharm.2021.121361"},{"key":"10.1016\/j.biopha.2026.119387_bib37","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1007\/s11095-010-0163-1","article-title":"Simulating dissolution of intravitreal triamcinolone acetonide suspensions in an anatomically accurate rabbit eye model","volume":"27","author":"Missel","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2026.119387_bib38","series-title":"Intravitreal Steroids","author":"Augustin","year":"2015"},{"key":"10.1016\/j.biopha.2026.119387_bib39","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/s41433-018-0021-7","article-title":"Clinical pharmacology of intravitreal anti-VEGF drugs","volume":"32","author":"Fogli","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.biopha.2026.119387_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/989501","article-title":"Intravitreal steroids for the treatment of retinal diseases","volume":"2014","author":"Sarao","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.biopha.2026.119387_bib41","first-page":"317","article-title":"Sustained release intraocular drug delivery devices for treatment of uveitis","volume":"6","author":"Haghjou","year":"2011","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.biopha.2026.119387_bib42","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1167\/iovs.08-2863","article-title":"Generation of a transgenic rabbit model of retinal degeneration","volume":"50","author":"Kondo","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2026.119387_bib43","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1471-4159.2008.05822.x","article-title":"PKG activity causes photoreceptor cell death in two retinitis pigmentosa models","volume":"108","author":"Paquet-Durand","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2026.119387_bib44","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3390\/ijms22031180","article-title":"Identification of novel substrates for cGMP Dependent Protein Kinase (PKG) through kinase activity profiling to understand its putative role in inherited retinal degeneration","volume":"22","author":"Roy","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119387_bib45","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1523\/JNEUROSCI.0133-09.2009","article-title":"NMDA receptor activation increases free radical production through nitric oxide and NOX2","volume":"29","author":"Girouard","year":"2009","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.biopha.2026.119387_bib46","doi-asserted-by":"crossref","first-page":"11487","DOI":"10.1074\/jbc.M007631200","article-title":"cAMP-dependent Protein Kinase Induces cAMP-response Element-binding Protein Phosphorylation via an Intracellular Calcium Release\/ERK-dependent Pathway in Striatal Neurons","volume":"276","author":"Zanassi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119387_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018191","article-title":"Activation of cGMP-dependent protein kinase stimulates cardiac ATP-sensitive potassium channels via a ROS\/calmodulin\/CaMKII signaling cascade","volume":"6","author":"Chai","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2026.119387_bib48","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00424-021-02556-9","article-title":"The role of cGMP-signalling and calcium-signalling in photoreceptor cell death: perspectives for therapy development","volume":"473","author":"Das","year":"2021","journal-title":"Pflug. Arch."},{"key":"10.1016\/j.biopha.2026.119387_bib49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/BST20110609","article-title":"Cross-talk between mitogenic Ras\/MAPK and survival PI3K\/Akt pathways: a fine balance","volume":"40","author":"Aksamitiene","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.biopha.2026.119387_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.573599","article-title":"Effect of AKT1 (p. E17K) hotspot mutation on malignant tumorigenesis and prognosis","volume":"8","author":"Chen","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119387_bib51","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1158\/1078-0432.CCR-16-0623","article-title":"PI3K\/Akt\/mTOR signaling and plasma membrane proteins are implicated in responsiveness to adjuvant dendritic cell vaccination for metastatic colorectal cancer","volume":"23","author":"Qian","year":"2017","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119387_bib52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41420-022-00897-7","article-title":"Kinase activity profiling identifies putative downstream targets of cGMP\/PKG signaling in inherited retinal neurodegeneration","volume":"8","author":"Roy","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biopha.2026.119387_bib53","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/cells12040617","article-title":"MAPK pathways in ocular pathophysiology: potential therapeutic drugs and challenges","volume":"12","author":"Moustardas","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119387_bib54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4049\/immunohorizons.1700035","article-title":"Interleukin-17 signaling triggers degradation of the constitutive NF-\u03baB inhibitor ABIN-1","volume":"1","author":"Cruz","year":"2017","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.biopha.2026.119387_bib55","doi-asserted-by":"crossref","first-page":"8995","DOI":"10.1038\/ncomms9995","article-title":"Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis","volume":"6","author":"Roth Flach","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119387_bib56","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/j.celrep.2018.04.111","article-title":"Aerobic glycolysis is essential for normal Rod function and controls secondary cone death in retinitis pigmentosa","volume":"23","author":"Petit","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2026.119387_bib57","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","article-title":"AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance","volume":"66","author":"Garcia","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2026.119387_bib58","first-page":"429","article-title":"AMP-activated protein kinase phosphorylates transcription factors of the CREB family","volume":"104","author":"Thomson","year":"2008","journal-title":"J. Appl. Physiol. Bethesda Md 1985"},{"key":"10.1016\/j.biopha.2026.119387_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001607","article-title":"Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer","volume":"8","author":"Hurkmans","year":"2020","journal-title":"J. Immunother. Cancer"}],"updated-by":[{"DOI":"10.1016\/j.biopha.2026.119601","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000}},{"DOI":"10.1016\/j.biopha.2026.119601","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226004221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226004221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:48:15Z","timestamp":1794476895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226004221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":59,"alternative-id":["S0753332226004221"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119387","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained intravitreal dissolution and kinase inhibition by an inhibitory cGMP analogue after its injection as a suspension of a poorly soluble salt","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119387"}}